Summary of earnings call for Jain Irrigation Systems Ltd published on 03 Nov, 2025
Jain Irrigation Systems Limited
Q2 FY26
Call date · October 30, 2025
1 · Management Commentary
Key Positives
- Revenue grew 20% YoY to Rs. 1,432 crores in Q2, with H1 growth at ~12%, despite a deflationary environment.
- EBITDA grew 43% YoY in Q2; all business segments (high-tech, plastics, agro-processing) showed stable to positive earnings growth.
- High-tech business grew 39%, plastics 9.5%, and agro-processing 15% in Q2.
- Export revenues robust: Rs. 129 crores in Q2, Rs. 259 crores in H1 (38% YoY growth).
- Strong operating cash flow: Rs. 190 crores net cash from operations in Q2 post working capital changes.
- Tissue culture business (banana) sold out; plans to increase capacity by 50% over 3 years.
Key Negatives
- Piping business remained soft due to prolonged monsoon and reduced government infrastructure spending.
- Receivables remain elevated (Rs. 2,000 crores), with significant exposure to state government projects.
- Net profit margin remains low (~1%), with high interest and depreciation costs impacting bottom line.
- Delays in government receivables collection; timelines for EPC project payments have shifted out to FY27.
Forward Guidance
- Capex: Capacity expansion in tissue culture (banana) and beverage bottling (food processing subsidiary); beverage bottling lines to be operational by March 2026.
- New products/segments: Entry into beverage bottling in collaboration with a global partner; additional capacity planned in FY27.
- Expected client wins/losses: Large diameter pipe projects (e.g., desalination) expected to contribute from Q4 and FY27.
- Revenue/margin outlook: Confident of >15% consolidated revenue growth in FY26; margin improvement targeted via product mix and deleveraging.
- Other initiatives: Focus on working capital efficiency, deleveraging, and expanding presence in North and North-East India for pipes.
2 · Q&A Highlights
Q 1 (Composite): How will the company manage debt repayment due in FY27, and what is the plan for working capital given high receivables?
A (Management):
• Debt repayment to be managed through internal accruals and legacy receivable collections; no new debt added for working capital in Q2.
• Expect at least Rs. 300-350 crores release from receivables in next 6 months; dealer business model reduces working capital needs.
Q 2 (Composite): What is the status and timeline for government/EPC receivables and project completion?
A (Management):
• Major EPC projects (5 remaining) to be completed by March 2026; most related receivables (~Rs. 900 crores) expected by March 2027.
• Receivables are spread across multiple states, mainly southern India; not overly exposed to any single state.
Q 3 (Composite): What is the execution timeline for the Rs. 1,900 crores order book, and how is it split between export/domestic?
A (Management):
• Rs. 1,500 crores to be executed by March 2026, Rs. 400 crores by September 2026; food orders have a 12-month cycle.
• Exports: Rs. 129 crores in Q2, Rs. 259 crores in H1 (38% YoY growth).
Q 4 (Composite): What is the expected revenue contribution from the new beverage bottling unit, and does FY26 guidance include this?
A (Management):
• First two lines to add Rs. 400–500 crores annual revenue at 65–75% utilization (full impact in FY27); FY26 guidance does not include significant bottling revenue.
Q 5 (Composite): What is the strategy to improve net profit margins, and how will deleveraging be achieved?
A (Management):
• Margin improvement targeted via higher capacity utilization, better product mix, and deleveraging; aim to move net margins from 1–2% to 5–7% over next few years.
Q 6 (Composite): What is the progress on tissue culture (coffee MOU) and future growth in this segment?
A (Management):
• Coffee tissue culture results positive; significant revenue expected post-FY27. Banana and pomegranate demand strong; tissue culture division to maintain >20% growth.
Q 7 (Composite): Is there a plan for IPO of Jain Foods?
A (Management):
• IPO for Jain Farm Fresh (Foods) planned for calendar year 2026, subject to market conditions and in consultation with private equity partner.
Q 8 (Composite): What is the strategy for expanding pipe business in North India and urban markets?
A (Management):
• Historically focused on rural/agri markets; now increasing focus on North and North-East India, with plans to expand urban/plumbing presence over next 1–2 years.
3 · Other Key Numbers
- Q2 FY26 revenue: Rs. 1,432 crores (Q2 FY25: Rs. 1,191 crores)
- H1 FY26 revenue: ~Rs. 3,000 crores
- Q2 FY26 EBITDA: Not disclosed (but 43% YoY growth)
- H1 FY26 EBITDA: Rs. 400 crores
- Q2 FY26 EBITDA margin: 13.9%
- High-tech EBITDA margin: ~19%
- Plastics EBITDA margin: Double-digit (exact % not disclosed)
- Agro-processing EBITDA margin: Improved to double-digit (exact % not disclosed)
- Net cash from operations (Q2): Rs. 190 crores (post working capital); Rs. 400 crores (pre working capital)
- Inventory: Rs. 1,000 crores
- Receivables: Rs. 2,000 crores (project-related: Rs. 900 crores; other government: Rs. 400 crores)
- Order book: Rs. 1,900 crores (Rs. 1,500 crores to be executed by March 2026)
- Export revenue: Rs. 129 crores (Q2), Rs. 259 crores (H1)
- Debt repaid in last 3.5 years: Rs. 1,300 crores (from operations), Rs. 3,000 crores (from overseas business sale)
- GST on drip irrigation reduced from 12% to 5%; GST on solar pumps also reduced
- Beverage bottling unit: Rs. 400–500 crores annual revenue potential at 65–75% utilization (from FY27)
- Tissue culture capacity to increase by 50% over 3 years
- Government project collections in FY23: Rs. 800 crores; FY24: Rs. 431 crores; prior year: Rs. 632 crores
- Net profit margin (Q2): ~1%
- Number of business segments: 6 (drip/sprinkler, plastic pipes, plastic sheet overseas, tissue culture, solar pumps, food processing)